UnitedHealth Q2 earnings surge 61% on lower medical costs, but membership declines
UNH sits 67% above its 52-week low of $244.37.
Summary
UnitedHealth's Q2 2026 earnings jumped 61% to $6.04 per share as medical costs fell sharply, but membership dropped by 1.6 million people amid pricing actions and Medicaid redeterminations.
Key Events · Earnings and Guidance · UNH
-
Q2 EPS Soars 61%
Diluted EPS of $6.04 vs $3.74 a year ago, driven by a 2.7 percentage point improvement in the medical care ratio to 86.7%.
-
Medical Costs Drop Sharply
Medical costs fell $3.2 billion to $75.4 billion, reflecting favorable prior-period reserve development of $1.25 billion and lower utilization.
-
Membership Declines by 1.6 Million
UnitedHealthcare served 1.6 million fewer people, with declines in Medicare Advantage (785,000), Medicaid (710,000), and commercial risk (785,000).
-
Operating Cash Flow Hits $20 Billion
Cash from operations for the first half of 2026 reached $20.0 billion, up from $12.6 billion a year ago, boosted by higher earnings and working capital.
Analysis · UNH · Finance
A sharp drop in the medical care ratio to 86.7% from 89.4% powered UnitedHealth Group to a massive Q2 beat, with diluted EPS of $6.04—up 61% from $3.74 a year ago. The improvement reflected favorable prior-period reserve development and disciplined cost management, even as the company shed 1.6 million members across Medicare Advantage, commercial risk, and Medicaid. Operating cash flow reached $20 billion for the half, and a $1.5 billion acquisition was completed. However, the IRS is challenging transfer pricing for 2017–2020, and membership losses signal ongoing pressure from Medicare funding cuts and state Medicaid rate disputes.
At the time of this filing, UNH was trading at $408.70 on NYSE in the Finance sector, with a market capitalization of approximately $371.2B. The 52-week trading range was $244.37 to $461.62. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.